← Leaderboards
Claudio Anasetti
Fred Hutchinson Cancer Research Center
$8,370,314
Attributed
$8,370,314
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $718K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,370,314 · 10
By mechanism
R01$6,002,615 · 4
U10$1,029,555 · 1
R21$824,212 · 2
P01$346,443 · 2
P30$167,489 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Rainer F. Storb$23,835,935
- Paul J Martin$18,480,958
- John Andrew Hansen$38,444,497
- Brenda Marie Sandmaier$22,185,663
- Beverly J Torok-Storb$23,179,515
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventDisorder PreventionTransplantationGraft-Vs-Host DiseaseClinical TrialsAllogenicImmunePreventionResponseT-LymphocyteAcute Graft Versus Host DiseaseProgramsCellsBone Marrow TransplantationSeveritiesMalignant NeoplasmsHematopoietic Stem Cell TransplantationImmunityHematologic NeoplasmsRegulatory T-LymphocyteHuman Herpesvirus 4DesignHematopoieticLeukemia
Grant awards (33)
Immunology$54,966
P30 · FY2019 · CA · contact PI
Immunology$48,718
P30 · FY2018 · CA · contact PI
Immunology$8,049
P30 · FY2018 · CA · contact PI
Immunology$3,751
P30 · FY2018 · CA · contact PI
Immunology$3,288
P30 · FY2018 · CA · contact PI
Immunology$48,717
P30 · FY2017 · CA · contact PI
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio$545,205
R01 · FY2016 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical C*$172,845
U10 · FY2016 · HL · contact PI
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio$500,640
R01 · FY2015 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical C*$172,845
U10 · FY2015 · HL · contact PI
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio$498,100
R01 · FY2014 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical C*$172,845
U10 · FY2014 · HL · contact PI
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio$468,268
R01 · FY2013 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical C*$172,845
U10 · FY2013 · HL · contact PI
Antigen Specific T Cell tolerance by Anti CD3 Antibodies$363,196
R01 · FY2012 · CA · contact PI
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical C*$172,845
U10 · FY2012 · HL · contact PI
Antigen Specific T Cell tolerance by Anti CD3 Antibodies$365,441
R01 · FY2011 · CA · contact PI
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical C*$165,330
U10 · FY2011 · HL · contact PI
Antigen Specific T Cell tolerance by Anti CD3 Antibodies$379,132
R01 · FY2010 · CA · contact PI
Peripheral T Cell tolerance by targeting AKT$208,750
R21 · FY2010 · AI · contact PI
Antigen Specific T Cell tolerance by Anti CD3 Antibodies$374,107
R01 · FY2009 · CA · contact PI
Peripheral T Cell tolerance by targeting AKT$250,250
R21 · FY2009 · AI · contact PI
Antigen Specific T Cell tolerance by Anti CD3 Antibodies$361,592
R01 · FY2008 · CA · contact PI
Antigen Specific T Cell Tolerance by Anti CD3 Antibodies$358,132
R01 · FY2006 · AI · contact PI
Antigen Specific T Cell Tolerance by Anti CD3 Antibodies$366,750
R01 · FY2005 · AI
Antigen Specific T Cell Tolerance by Anti CD3 Antibodies$366,750
R01 · FY2004 · AI
Antigen Specific T Cell Tolerance by Anti CD3 Antibodies$368,041
R01 · FY2003 · AI
Antigen Specific T Cell Tolerance by Anti CD3 Antibodies$386,909
R01 · FY2002 · AI
TOLERANCE AFTER HEMATOPOIETIC STEM CELL GRAFTS$0
P01 · FY2002 · CA
Antigen Specific T Cell Tolerance by Anti CD3 Antibodie$365,212
R21 · FY2001 · AI
TOLERANCE INDUCTION BY THERAPEUTIC MONOCLONAL ANTIBODIES$0
P01 · FY2001 · CA
TOLERANCE INDUCTION BY THERAPEUTIC MONOCLONAL ANTIBODIES$346,443
P01 · FY2000 · CA
ANTIGEN SPECIFIC T CELL TOLERANCE BY ANTI CD3 ANTIBODIES$300,352
R01 · FY2000 · AI